Literature DB >> 16518332

Renal stone epidemiology in Rochester, Minnesota: an update.

J C Lieske1, L S Peña de la Vega, J M Slezak, E J Bergstralh, C L Leibson, K-L Ho, M T Gettman.   

Abstract

Studies in Western countries have suggested an increasing incidence of nephrolithiasis (NL) in the latter part of the 20th century. Therefore, we updated NL epidemiology data for the Rochester population over the years 1970-2000. All Rochester residents with any diagnostic code that could be linked to NL in the years of 1970, 1980, 1990, and 2000 were identified, and the records reviewed to determine if they met the criteria for a symptomatic kidney stone as defined in a previous Rochester, MN study. Age-adjusted incidence (+/-s.e.) of new onset symptomatic stone disease for men was 155.1 (+/-28.5) and 105.0 (+/-16.8) per 100,000 per year in 1970 and 2000, respectively. For women, the corresponding rates were 43.2 (+/-14.0) and 68.4 (+/-12.3) per 100,000 per year, respectively. On average, rates for women increased by about 1.9% per year (P=0.064), whereas rates for men declined by 1.7% per year (P=0.019). The overall man to woman ratio decreased from 3.1 to 1.3 during the 30 years (P=0.006). Incident stone rates were highest for men aged 60-69 years, whereas for women, they plateaued after age 30. Therefore, since 1970 overall NL incidence rates in Rochester have remained relatively flat. However, NL rates for men have declined, whereas rates for women appear to be increasing. The reasons remain to be determined.

Entities:  

Mesh:

Year:  2006        PMID: 16518332     DOI: 10.1038/sj.ki.5000150

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  71 in total

1.  Urolithiasis in a rural Wisconsin population from 1992 to 2008: narrowing of the male-to-female ratio.

Authors:  Kristina L Penniston; Ian D McLaren; Robert T Greenlee; Stephen Y Nakada
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

2.  Temporal trends in incidence of kidney stones among children: a 25-year population based study.

Authors:  Moira E Dwyer; Amy E Krambeck; Eric J Bergstralh; Dawn S Milliner; John C Lieske; Andrew D Rule
Journal:  J Urol       Date:  2012-05-15       Impact factor: 7.450

Review 3.  Epidemiology of stone disease.

Authors:  Gary C Curhan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

4.  Regional and seasonal variation in the incidence of urolithiasis in Iran: a place for obsession in case finding and statistical approach.

Authors:  Abbas Basiri; Nasser Shakhssalim; Ali Reza Khoshdel; Mohsen Naghavi
Journal:  Urol Res       Date:  2009-05-26

5.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

6.  Analgesic Effects of Inhalation of Nitric Oxide (Entonox) and Parenteral Morphine Sulfate in Patients with Renal Colic; A Randomized Clinical Trial.

Authors:  Hamid Kariman; Alireza Majidi; Sara Taheri; Ali Shahrami; Hamid Reza Hatamabadi
Journal:  Bull Emerg Trauma       Date:  2015-04

7.  Kidney Stone Recurrence among Children and Adolescents.

Authors:  Gregory E Tasian; Abdo E Kabarriti; Angela Kalmus; Susan L Furth
Journal:  J Urol       Date:  2016-08-10       Impact factor: 7.450

8.  Female stone disease: the changing trend.

Authors:  Y M Fazil Marickar; Adarsh Vijay
Journal:  Urol Res       Date:  2009-09-25

9.  Incidence of upper urinary tract stone during 15 years in Tajima area, Japan: a hospital-based study.

Authors:  Takeshi Takahashi; Akifumi Yamane; Kosuke Okasho; Takeshi Yoshikawa; Harutake Sawazaki; Syodo Wataru; Yoji Taki; Hideo Takeuchi
Journal:  Urol Res       Date:  2009-09-25

Review 10.  Diet: from food to stone.

Authors:  Justin I Friedlander; Jodi A Antonelli; Margaret S Pearle
Journal:  World J Urol       Date:  2014-06-18       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.